Ocular graft-versus-host disease (GVHD) is common in patients with GVHD due to systemic inflammation (IMAGE)

Fujita Health University

Ocular graft-versus-host disease (GVHD) is common in patients with GVHD due to systemic inflammation

Caption

Researchers from Japan have found that treatment with mesenchymal stromal cells (MSCs) increased regulatory T cells while decreasing inflammatory TH1 and TH17 cells, highlighting MSCs' potential as a novel treatment to prevent ocular complications associated with GVHD.

Credit

Lone Primate on Open Verse

Usage Restrictions

Credit must be given to the creator. Only noncommercial uses of the work are permitted. Adaptations must be shared under the same terms.

License

CC BY-NC-SA

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.